Omega Fund Management as of Sept. 30, 2018
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 14 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Replimune Group (REPL) | 38.9 | $82M | 5.1M | 16.10 | |
| Paratek Pharmaceuticals | 11.9 | $25M | 2.6M | 9.70 | |
| Translate Bio | 11.5 | $24M | 2.4M | 10.00 | |
| Obseva Sa | 8.5 | $18M | 999k | 18.03 | |
| Kezar Life Sciences (KZR) | 7.0 | $15M | 693k | 21.41 | |
| Sienna Biopharmaceuticals (SNNAQ) | 5.3 | $11M | 759k | 14.82 | |
| Fibrogen (FGEN) | 3.8 | $7.9M | 131k | 60.75 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 3.1 | $6.6M | 1.5M | 4.40 | |
| Cymabay Therapeutics | 2.9 | $6.1M | 552k | 11.08 | |
| Pieris Pharmaceuticals | 2.1 | $4.4M | 778k | 5.60 | |
| Jounce Therapeutics | 1.6 | $3.4M | 530k | 6.50 | |
| Dicerna Pharmaceuticals | 1.6 | $3.4M | 224k | 15.26 | |
| Essa Pharma (EPIX) | 1.5 | $3.3M | 1.1M | 3.00 | |
| Egalet | 0.2 | $347k | 2.9M | 0.12 |
